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OBJECTIVES: Our goal is to validate diagnosing and characterizing epilepsy based on a medical record sur-
vey by external reviewers.
METHODS: We reviewed medical records from 80 patients who received antiepileptic drugs in 2009 at two 
hospitals. The study consisted of two steps; data abstraction by certified health record administrators and then 
verification by the investigators. The gold standard was the results of the survey performed by the epileptolo-
gists from their own hospital.
RESULTS: The specificity was more than 90.0% for diagnosis and activity, and for new-onset seizures. The 
sensitivity was 97.0% or more for diagnosis and activity and 66.7-75.0% for new-onset epilepsy. This method 
accurately classified epileptic syndromes in 90.2-92.9% of patients, causes in 85.4-92.7%, and age of onset in 
78.0-81.0%. Kappa statistics for inter-rater reliability and test-retest reliability ranged from 0.641-0.975, which 
means substantial to near-perfect agreement in all items.
CONCLUSIONS: Our data suggest that epilepsy can be well identified by external review of medical records. 
This method may be useful as a basis for large-scale epidemiological research.
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INTRODUCTION
The Korean National Health Insurance (NHI) has provided 
health care for the entire Korean population as well as all medi-
cal facilities since 1989 and its database is a useful source of 
data for epidemiological research. Our previous study demon-
strated its value in estimating the national prevalence of epilep-
sy based on antiepileptic drugs (AEDs) prescribed and diagnos-
tic codes for claims [1]. However, NHI data should be validated 
for epidemiological research [2,3]. In addition, the NHI data do 
not provide detailed clinical information. Therefore, we launched 
the Epidemiological Study of Seizure and Epilepsy using Na-
tionwide database for Corean Epilepsy patients (ESSENCE) 
project to estimate the prevalence of epilepsy from NHI data, 
which were validated and supplemented by a review of medi-
cal records. 
Surveys reviewing medical records hold an advantage over 
door-to-door surveys, as they prevent recall errors, and clinical 
details as well as laboratory results are readily available [4]. When 
easy access to care providers is guaranteed in a national health 
care system, a review of medical records can be utilized in un-
derstanding the epidemiology of certain disorders. To ensure ef-
ficiency and consistency of the overall study, the task of review-
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ing medical records was carried out by trained external review-
ers. The goal of this study was to develop a protocol for and eval-
uate the validity and reliability of medical record survey for ep-




The two study hospitals, Korea University Hospital (K hospi-
tal located in Seoul) and Eulji University Hospital (E hospital 
located in a suburban area), are both tertiary centers. K hospi-
tal has an electronic medical record system, whereas E hospital 
does not.
Among those who were prescribed AEDs during the year 
2009, 80 patients were randomly selected from the NHI claims 
data from both hospitals. To guarantee an adequate representa-
tion of various conditions, for each hospital, we sampled 18 pa-
tients coded as having epilepsy or seizure, 12 as having central 
nervous system (CNS) illness other than epilepsy or seizure, 
and 10 without any diagnostic codes related to CNS disease. 
AEDs included carbamazepine, clobazam, ethosuximide, gaba-
pentin, lamotrigine, levetiracetam, oxcarbazepine, phenobarbi-
tal, phenytoin, pregabalin, topiramate, vigabatrin, valproate, 
and zonisamide. Clonazepam was excluded because it is rarely 
used as monotherapy for epilepsy and is more frequently used 
for non-epileptic purposes. Other anticonvulsants, including 
primidone, felbamate and tiagabin were not available in 2009 
in Korea. The diagnostic codes indicating epilepsy or seizure in-
cluded G40* (epilepsy), G41* (status epilepticus), F803 (Lan-
dau-Kleffner syndrome), and R56.8 (convulsion), based on the 
10th version of the International Classification of Diseases (ICD-
10) and related health problems [5]. This study was approved 
by the Institutional Review Board of Korea University Hospital 
(AN10221-001). 
Procedures
The investigators developed a case recording form (CRF) and 
common diagnostic algorithm, which was tested for consistency. 
The CRF consisted of two parts: the first part was a preliminary 
form for chart abstraction, written in layman terms and includ-
ed guidelines for surveyors; the second part was the verification 
form, which included the diagnostic algorithm for epileptolo-
gists (Appendix).
Part one documented demographics, ICD-10 codes, depart-
ment of primary physician, diagnosis, antiepileptic drugs pre-
scribed, history of seizures, recurrence of seizures, age of onset, 
new-onset seizure or presence of any seizure during 2009, de-
scription of seizure type, cause of epilepsy, electroencephalog-
raphy (EEG) and brain imaging results. Age of onset was classi-
fied as <12 months, 12 months-6 years, 6 years-12 years, 12 
years-18 years, 18 years-30 years, 30 years-60 years, and >60 
years. EEG findings were categorized as normal, abnormal with 
focal epileptiform discharges, abnormal with generalized epi-
leptiform discharges, and abnormal with non-epileptiform dis-
charges.
Part two consisted of diagnosis, activity of epilepsy, cause, and 
classification of epilepsy. Diagnoses were categorized as: 1) epi-
lepsy; 2) single seizure; 3) either epilepsy or seizure, unclear; 4) 
non-epileptic; and 5) either epileptic or non-epileptic, unclear. 
Epilepsy was defined as having two or more seizures during 
the patient’s lifetime. In cases where it was uncertain whe ther 
he or she had single seizure or recurrent seizures, category 3 
was assigned. Acute symptomatic seizures were categorized as 
3, even if they were recurrent. If the AED was being used for 
other identifiable reasons such as pain, the patients were classi-
fied as being category 4. If the reason for prescribing an AED 
could not be determined, category 5 was assigned. Active epi-
lepsy was defined as one or more seizures during 2009. The 
etiology was determined based on the clinical history, findings, 
brain imaging results, and EEG. If there were conflicting data, 
the etiology was determined by the clarity of the records and 
additional explanation from the treating physician. Non-specific 
imaging findings, such as small vessel disease, arachnoid cysts, 
venous anomalies, or diffuse atrophy were not considered as 
causes of epilepsy. Epilepsy was classified as: 1) generalized; 2) 
localization-related; 3) undetermined as to whether focal or 
generalized; 4) special syndrome, according to International 
League Against Epilepsy classification [6]; 5) and a lack of in-
formation for classification, based on the seizure type, syndrome 
diagnosis documented by the clinician, brain imaging, and EEG 
in the order of priority. Patients who had only generalized ton-
ic-clonic seizures (GTCSs) with normal EEG and brain imaging 
were classified as 3. Patients who had only GTCSs with normal 
EEG but without any brain imaging results were classified as 5.
For chart abstraction, we recruited certified health record ad-
ministrators (HRAs) who were experienced in reviewing medi-
cal records for epidemiological studies and health registry.  These 
were coders certified by the Department of Ministry and Health 
Care of Korea for abstracting and managing data from medical 
records. The HRAs were intensively trained to review medical 
records and extract data related to epilepsy for 8 hours. The di-
dactic portion included an overall introduction, a general over-
view on epilepsy, medical terminology and abbreviations com-
monly used in physicians’ notes, how to find test results, and 
other conditions in the differential diagnosis or that are treated 
with AEDs. The HRAs then received hands-on training in com-
pleting the CRFs while receiving feedback from the epileptolo-
gists, until they achieved a high level of concordance with the 
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epileptologists. Training was provided at a third-party hospital.
In this study, we assessed the validity and reliability of reviews 
performed by two HRAs (HRA-A and B), followed by verifica-
tion by an external epileptologist (included SY Lee). HRA-A 
repeated the review at a 1-month interval to determine test-re-
test reliability.  To establish a gold standard, each epileptologist 
perform ed both steps of chart abstraction and verification at his 
or her own hospital (E hospital, K hospital). In addition, alter-
native sources, such as the individual hospital data for patients 
with epilepsy or physician opinions were incorporated into the 
gold standard. The design of the study is summarized in Figure 1.
We analyzed the validity and reliability of the six items: diag-
nosis, activity of epilepsy, cause, classification (all verified by 
the epileptologist), new-onset epilepsy, and age of onset (ob-
tained by the HRAs without verification by the epileptologist). 
The validity of the survey was estimated by measuring sensitiv-
ity and specificity. For multiple-choice items, we estimated the 
rate of the correct diagnosis. The level of reliability was estimat-
ed by kappa value, and graded to almost perfect (κ=0.81-1.0), 
substantial (κ=0.61-0.80), moderate (κ=0.41-0.60), fair (κ=0.21-
0.40), or slight (κ=0.0-0.2) agreement, according to the classifi-
cation system suggested by Landis and Koch [7]. Statistical anal-
ysis was performed using SPSS version 18.0 (SPSS Inc., Chica-
go, IL, USA). 
RESULTS
Baseline characteristics 
Of the total 80 subjects, 46 (57.5%) were men and the mean 
age of subjects was 48.1 years old (range 9-88). Thirty-nine sub-
jects had epilepsy, one had a single seizure, and two had seizure 
but it was unclear whether this recurred or not. Thirty-seven 
subjects received AEDs for non-epileptic causes; among them, 
29 received AEDs for neuropathic pain, 4 for prophylaxis of 
seizure after brain insult or surgery, and the others for hemifa-
cial spasm, facial nerve injury, oromandibular dyskinesia, or 
cramps. There was one case where the diagnosis was unclear 
(Table 1).
Validity
The sensitivity, specificity, and reliability of each surveyor are 
summarized in Table 2. For the diagnosis of epilepsy, the sensi-
tivity was 97.6% for HRA-A and 100% for HRA-B, and speci-
ficity was 94.9% for HRA-A and 97.4% for HRA-B. For the ac-
tivity of epilepsy, sensitivity was 100.0% for HRA-A and 97.0% 
for HRA-B, and specificity was 100.0% for both. For new-onset 
epilepsy, specificity was 90.9% for HRA-A and 100.0% for 
HRA-B, whereas sensitivity was 75.0% for HRA-A and 66.7% 
for HRA-B. The age of onset was correctly identified in 78.0% 
by HRA-A and 81.0% by HRA-B. The cause and classification 
of epilepsy were correctly identified and classified in 85.4% 
Table 1. Patient demographics (n=80)
Clinical characteristics of study patients n







1. Epilepsy or seizure
2. CNS diseases other than epilepsy or seizure







3. Either epilepsy or seizure, unclear
4. Non-epileptic
    Prophylaxis for seizure
    Pain
    Other (hemifacial spasm, facial nerve injury,  
       oromandibular dyskinesia, and cramps)










CNS, central nervous system.
Figure 1. Study design for validation of medical record survey. The 
survey consisted of two-step data collection by certified health re-
cord administrators (HRAs) and then verification by the study epi-
leptologist (Epi-S). For validation purposes, the gold standard was 
the conclusion each epileptologist made for his own hospital (Epi-
OH), E or K hospital. In order to determine inter-rater reliability, two 
HRAs (HRA-A and HRA-B) reviewed medical records of the same 
patient while being blinded to each other. HRA-A repeated the re-
views at a 1-month interval to determine test-retest reliability. CRF, 
case record form; HRA-A or B, health record administrator A or B; 
Epi-OH, epileptologist from the hospital; Epi-S, study epileptologist.
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and 90.2% of cases, respectively for HRA-A, and 92.7% and 
92.9%, respectively for HRA-B. 
Inter-rater reliability between HRA-A and B was almost per-
fect for the diagnosis (κ=0.907), disease activity (κ=0.932), and 
classification of epilepsy (κ=0.864). For new-onset epilepsy, age 
of onset, and cause of epilepsy, the reliability was substantial 
(κ=0.728, κ=0.753, and κ=0.792, respectively).
The reliability of repeated examination was almost perfect for 
the diagnosis of epilepsy (κ=0.975) and substantial for disease 
activity, new-onset epilepsy, age of onset, cause, and classifica-
tion of epilepsy (κ=0.796, κ=0.641, κ=0.697, κ=0.693, and 
κ=0.787, respectively). 
DISCUSSION
Our medical record review method demonstrated high levels 
of validity and consistency for the assessment of diagnosis, ac-
tivity, and classification of epilepsy. The validity and reliability 
with regard to new-onset epilepsy, age of onset, and cause were 
acceptable.
The source of data from epidemiological studies may origi-
nate from direct population surveys, information or registries 
from physicians, medical records, or administrative data. Direct 
population surveys usually also involve interviews by non-phy-
sician surveyors or self-recorded questionnaires [8,9]. Some stu-
dies have validated questionnaires as a method to diagnose pa-
tients with epilepsy [8,9]. 
Reviewing medical records is highly useful to validate and 
supplement information from administrative data [8]. Review-
ing of medical records is often performed by non-physician re-
viewers such as nurses or medical students, with or without a 
specialist’s verification in epidemiological studies for epilepsy 
[9-11]. It would be ideal for the treating physicians to survey 
their own patients. However, not all of them are epileptologists 
and differences in experience would affect the consistency of 
the overall data. Although a standard protocol to confirm the 
diagnosis of epilepsy via medical records for epidemiological 
studies is not available, we are unaware of any other studies 
that have validated their tools. We showed that our non-physi-
cian reviewers could collect data that were sufficient for the epi-
leptologists to diagnose epilepsy.
It is one of the limitations of our study that the gold standard 
was derived from medical records, lacking a face-to-face inter-
view. We could not conclude which factors affected the validity, 
such as the type of medical record system or institution, spe-
cialties of physicians prescribing AEDs, or diagnostic codes, due 
to the small sample size.
Our results suggest that trained health care workers’ review 
of medical records followed by verification by an epileptologist 
is a valid and consistent way to identify and characterize epi-
lepsy patients. This allows large-scale epidemiological studies 
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Appendix
- 1 - 
 
Epilepsy Case Recording Form (CRF) 
 
Date of 
Survey    yr   m   d  
Institution 
code  
DOB Gender Home address  (City/ Gu) 
yr   m   d ○ m ○ f  
 
■ Medical insurance claims data 
Diagnostic codes   Primary diagnostic code  Secondary diagnostic code   
○ Epilepsy or seizure ○ G40* ○ G41* ○ G40* ○ G41* 
○ Other    ______________ ○ F803*  ○ R56* ○ F803*  ○ R56* 
If there was no codes for epilepsy or seizure, please document the codes given. 
Antiepileptic medication ▶ can be multiple 
○  Carbamazepine ○  Lamotrigine ○  Pregabalin ○  Phenytoin 
○  Clobazam ○  Levetiracetam ○  Topiramate ○  Zonisamide 
○  Ethosuximide ○  Oxcarbazepine ○  Vigabatrin   
○  Gabapentin ○  Phenobarbital ○  Valproate   
Dept of the physician who prescribed the antiepileptic medication(s)  
○ Neurology ○ Neurosurgery ○ Pediatrics ○ Psychiatry ○ Other 
 
■ Medical Records (clinical impression) 
: 1)    ____________________________                       2) ____________________________                      
3)    ____________________________                       4) ____________________________                          
* in chronological order 
 
■ Identification of seizure  It can be described as seizure, sz, fit, GTCS, aura, or a specific symptom. 
 For example: clonus, head drop, loss of consciousness, altered mental status, abnormal behavior, falls, etc.  
1. Any history of seizure ○ Yes ○ No ○ Unclear  
2. History of repetitive seizures ○ Yes ○ No ○ Unclear  
3. What was the indication for prescribing antiepileptic medication if the patient did not have a seizure?  
○  Pain: abnormal sensation, paresthesias; headache, herpes 
zoster, diabetes,  polyneuropathy , trigeminal neuralgia, 
etc. 
○ Possible seizure  
antiepileptic medications were used despite lack of 
objective evidence as follows: 
ib 
○  Hemifacial spasm    ○ Loss of consciousness, LOC  
○ Obesity   ○ Unusual behavior- amnesia, wandering, agitation 
○ Seizure prophylaxis - neurosurgery/head trauma /brain tumor  ○ Falls 
○ Other   __________________________________                                  ○ Tremor, twitching 
○ Unclear  ○ Other ______________________________                             
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■ Details of Epilepsy 
4. Did the patient have any seizure in 2009?  
(if there was no description about seizure, consider as no seizure; An 
aura should be considered a seizure) 
○ Yes ○ No 
5. Did the seizures start in 2009?  ○ Yes ○ No ○ Undetermined 
6. When did the seizures start?  
○  <12months (infant)  ○  18~<30 years  
○  12months~<6 years (toddler, preschool) ○  30~<60 years 
○  6~<12 years (elementary school) ○  >60 years 
○  12~<18 years (middle or high school age ) ○        Undetermined 
7. Does the patient have auras? ○ Yes ○ No ○ Undetermined 
▶ can be multiple 
○ Epigastric rising sensation ○ Memory flashbacks 
○ Nausea, vomiting ○ (Un-)familiarity, jamais-vu, deja-vu 
○ Visual  ○ Paresthesias 
○ Auditory  ○ Unexplainable feelings, cephalic aura 
○ Dizziness (should be differentiated from adverse effect of drug or nonspecific symptoms) ○ Other ______________________________                        
8. Type of seizure? ▶ can be multiple 
○ Generalized seizure (GS) ○ Absence or petit mal 
○ Generalized tonic clonic, grand mal or GTCS ○ Atonic (drop attacks) 
○ Secondary generalized or secondary GTCS  ○ Spasms 
○ Partial seizure (PS), simple partial seizure (SPS), or 
complex partial seizure (CPS) ○ Other ____________________________                        
○ Myoclonus ○ Undetermined 
 
9. Cause of epilepsy? ▶ based on past medical history and doctor’s description; can be multiple 
○ Traumatic brain injury such as subdural hemorrhage (SDH), epidural hemorrhage (EDH), traumatic subarachnoid hemorrhage (tSAH), or contusion 
○ CNS infection 
○ Stroke, cerebral infarction, intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), Moyamoya disease 
○ Vascular malformation, arteriovenous malformation (AVM), cavernous angioma (CA) 
○ Brain tumor- oma, DNT, DNET 
○ Degenerative disorders: dementia such as Alzheimer’s (AD) or frontotemporal dementia (FTD) 
○ Perinatal injury or perinatal ischemia, cerebral palsy 
○ Congenital malformations of brain: malformation of cortical development (MCD), cortical dysplasia (CD), 
schizencephaly, pachygyria (lissencephaly), polymicrogyria, or heterotopia  
○ Hippocampal sclerosis, HS, hippocampal atrophy 
○ Other __________________________________________ 
○ No identifiable cause (idiopathic or cryptogenic) 
○   Lack of information with regard to cause 
 
8
Epidemiology and Health  2013;35:e2013006
 
10. Epileptic syndrome? ▶ check all the clinical impressions in medical records; please document the final 
impression here given ___________ 
○ Yes ○ No Ⅰ. Partial or focal epilepsy 
○ Localization-related epilepsy (LRE) ○ Occipital lobe epilepsy (OLE) 
○ Temporal lobe epilepsy (TLE) ○ Parietal lobe epilepsy (PLE) 
○ Frontal lobe epilepsy (FLE) ○ Benign rolandic epilepsy (BRE) 
○  Childhood epilepsy with occipital paroxysms (CEOP)  
 
○ Panayiotopoulos syndrome 
○ Gastaut type 
○ Other (anterior, posterior, left, right, central, insula etc) ______________________ 
 
○ Yes ○ No Ⅱ. Generalized epilepsy 
○ Childhood absence epilepsy (CAE) 
○ Juvenile absence epilepsy (JAE) 
○ Juvenile myoclonic epilepsy (JME) 
○ Idiopathic generalized epilepsy (IGE) 
○ Epilepsy with generalized tonic-clonic seizures (GTCS) on awakening  
○ Lennox-Gastaut syndrome (LGS) 
○ Infantile spasms or West syndrome  
○ Epilepsy with myoclonic-astatic seizures (Doose syndrome) 
○ Epilepsy with myoclonic absences (MAE) 
○ Early myoclonic encephalopathy (EME) 
○ Early infantile epileptic encephalopathy (EIEE) (Ohtahara syndrome) 
○ Benign neonatal convulsions  
○ Benign myoclonic epilepsy in infancy 
 
○ Yes ○ No Ⅲ. Undetermined whether partial or generalized 
○ Severe myoclonic epilepsy in infancy (SMEI) (Dravet syndrome) 
○ Generalized epilepsy with febrile seizures plus (GEFS plus) 
○ Landau-Kleffner syndrome (LKS) 
○ Continuous spikes and waves during slow sleep (CSWS) 
 
○ Yes ○ No 
 
IV. Special syndrome 
○ Febrile convulsion (febrile seizure, FC) 
○ Seizures occurring only when there is an acute metabolic or toxic event due to factors such as 
alcohol, drugs, eclampsia, or nonketotic hyperglycemia 
 
○ Yes ○ No  
 
V. No documentation of an epileptic syndrome 
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■ Diagnostic tests 
▶ Search the interpretation results in order communication system or electric medical record first, then in the clinician’s note. 
11. Has the patient had an EEG? ○ Yes ○ No 
11-1. What were the EEG 
results? 
○ Normal ○ Abnormal  
▶ If an EEG was reported abnormal even once choose ‘abnormal’. 
○ Yes ○ No  spikes, sharp waves, epileptiform discharges, rhythmic, ictal or epilepsy (do not 
include arrhythmic slowing) 
  ○ Generalized or diffuse (spike distribution) 
 ○ Localized or focal (suggestive of seizure focus) 
     Other abnormality                                                                     
 
12. Has the patient had a Brain MRI or CT?  
○ Yes ○ No MRI  (date           yr        m) 
○ Yes ○ No CT  (date           yr        m) 
12-1. What were the brain 
imaging results? ○ Normal ○ Abnormal ____________________________________________  
 
▶ If the report is too long, please attach the copy. 
▶ Document only the results obtained prior to seizure onset; for example, traumatic brain injury after 
having a seizure would not be applicable. 
Can be multiple 
○ Localized abnormality in cerebral hemisphere, cortex, or lobe  
○ Localized abnormality in deep graymatter-basal ganglia, thalamus; brainstem-midbrain, pons, medulla; white 
matter 
○ Diffuse abnormalities: diffuse atrophy, hydrocephalus 
○ Nonspecific: small vessel disease (SVD), unspecified bright opacities (UBO) 
○ Trauma: subdural hematoma (SDH), epidural hematoma (EDH), traumatic SAH, contusion 
○ Encephalitis, CNS infection 
○ Stroke, cerebral infarction, cerebral hemorrhage, ICH, SAH, Moyamoya disease 
○   Arteriovenous malformation (AVM), cavernous angioma (CA) 
○ Brain tumor- oma, DNT, DNET 
○ Degenerative disease: dementia such as Alzheimer’s (AD) or frontotemporal dementia (FTD) 
○ Perinatal injury or perinatal ischemia, cerebral palsy 
○ Congenital malformations of brain: malformation of cortical development (MCD), cortical dysplasia (CD), schizencephaly, pachygyria (lissencephaly), polymicrogyria, heterotopia  
○ Hippocampal sclerosis or atrophy 
○ Tuberous sclerosis or tubers 
○ Cerebromalacia, encephalomalacia or localized atrophy of unknown pathology 
○ Other     __________________________________________ 
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○  Epilepsy  Both 1& 2: Yes 
○  Single seizure 1: Yes, & 2: No 
○  Seizure or Epilepsy, unclear 1: Yes, & 2: Undetermined 
○  Other (nonseizure/nonepileptic) 1: No or Undetermined, & 3: Other cause 
○  Epileptic or nonepileptic, unclear 1 Undetermined, & 3 Undetermined 
■ Active epilepsy 
○ Yes ○ No If yes in item 4, yes 
 
■ Cause of epilepsy (can be multiple) 
 
▶Choose based on items 9 or 12. If there is conflicting data, 12 would hold priority, however, this would depend on the accuracy of 
the records and probability. 
▶Cases marked as stroke, vascular malformation, tumor, congenital malformation on 9, but normal on 12 would be defined as 
undetermined 
▶Cases marked as trauma on 9, but normal on 12 would be determined based on the accuracy of clinical information 
▶Cases marked as CNS infection or degenerative disease on 9, but normal on 12 will be determined as 9 
▶Cases marked as no specific cause on 9 and normal on 12 will be considered as idiopathic or cryptogenic 
○  Traumatic brain injury (mild head injuries are not to be considered a cause), SDH, EDH, traumatic SAH, 
contusion 
○ CNS infection 
○ Stroke, cerebral infarction, cerebral hemorrhage, ICH, SAH 
○ Arteriovenous malformation AVM, cavernous angioma CA 
○ Brain tumors 
○ Degenerative disorders: dementia such as Alzheimer’s (AD) or frontotemporal dementia (FTD) 
○ Perinatal injury or perinatal ischemia, cerebral palsy 
○ Congenital malformations of brain: malformation of cortical development (MCD), cortical dysplasia (CD), 
schizencephaly, pachygyria (lissencephaly), polymicrogyria, heterotopia  
○ Hippocampal sclerosis or atrophy 
○ Other ____________________________________(lesion of unknown pathology - cerebromalacia (trauma or 
stroke), cortical thickening (cortical dysplasia or tumor))                                                       
○ No identifiable cause (idiopathic or cryptogenic) 
○ Missing information on cause 
 
Date of Survey yr      m     d  
Institution code  
 
11
Kang BS et al.: Validity of Epilepsy Survey by External Records Review
■ Classification of Epilepsy 
▶Classification is based on the seizure type (7-8), diagnosed syndrome (10) clinical information, brain 
imaging (12), and EEG (11) (in the order of priority) 
▶Seizure, or GTCS without any specific description -> undetermined 
○  1) Localization-related epilepsy: the presence of one or more of the findings below without any findings to suggest generalized epilepsy 
○ Partial seizures  
 
○ Aura 
○ Simple partial seizure, or complex partial seizure 
 ○ Secondary generalized or secondary GTCS  
○ Localization-related epilepsy (LRE), documented by physician 
○ Temporal lobe epilepsy (TLE), documented by physician 
○ Frontal lobe epilepsy (FLE), documented by physician 
○ Occipital lobe epilepsy (OLE), documented by physician 
○ Parietal lobe epilepsy (PLE), documented by physician 
○ Benign rolandic epilepsy (BRE), documented by physician 
○ Childhood epilepsy with occipital paroxysm (CEOP), documented by physician 
 ○  Panayiotopoulos syndrome, documented by physician 
 ○  Gastaut type, documented by physician 
○ CT/MRI: localized abnormality in hemisphere cf. mild small vessel disease or unspecified bright opacity 
(UBO) is not considered as cause 
○ EEG: localized spikes  
○  (history) 
○  Traumatic brain injury (trivial head trauma is not considered as cause) SDH, EDH, traumatic SAH, 
contusion 
○ CNS infection 
○ Stroke, cerebral infarction, cerebral hemorrhage, ICH, SAH 
○ Arteriovenous malformation AVM, cavernous angioma CA 
○ Brain tumor 
○ Degenerative disorders: dementia such as Alzheimer’s (AD) or fontotemporal dementia (FTD) 
○ Perinatal injury or perinatal ischemia, cerebral palsy 
○ Congenital malformations of brain: malformation of cortical development (MCD), cortical dysplasia (CD), 
schizencephaly, pachygyria (lissencephaly), polymicrogyria, heterotopia  
○ Hippocampal sclerosis or  atrophy 
○ Tuberous sclerosis or tubers 
○ Other (lesion of unknown pathology - cerebromalacia (trauma or stroke), cortical thickening (cortical 
dysplasia or tumor)) 
Cause
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○ Generalized seizure  
○ Absence   
○ Myoclonus  
○ Atonic seizure  
 ○ Spasm 
○   Childhood absence epilepsy (CAE), documented by physician 
○   Juvenile absence epilepsy (JAE), documented by physician 
○   Juvenile myoclonic epilepsy (JME), documented by physician 
○   Idiopathic generalized epilepsy (IGE), documented by physician 
○ Epilepsy with generalized tonic -clonic seizures (GTCS) on awakening, documented by physician 
○ Lennox-Gastaut syndrome (LGS), documented by physician 
○ Infantile spasms (IS) or West syndrome, documented by physician 
○ Epilepsy with myoclonic-astatic seizures (Doose syndrome), documented by physician 
○ Epilepsy with myoclonic absences (MAE), documented by physician 
○ Early myoclonic encephalopathy (EME), documented by physician 
○ Early infantile epileptic encephalopathy (EIEE) (Ohtahara syndrome), documented by physician 
○ Benign neonatal convulsions , documented by physician 
○ Benign myoclonic epilepsy in infancy, documented by physician 
○ EEG: generalized spike 
○ 3) Undetermined whether partial or generalized 
○ Severe myoclonic epilepsy in infancy (SMEI) (Dravet syndrome), documented by physician 
○ Generalized epilepsy with febrile seizures plus (GEFS plus), documented by physician 
○ Landau-Kleffner syndrome (LKS), documented by physician 
○ Continuous spikes and waves during slow sleep (CSWS), documented by physician 
○ Seizures without unequivocal generalized or focal features (including cases with only GTCS) 
○ 4) Special syndrome 
○ Febrile convulsion (febrile seizure, FC) 
○ Seizures occurring only when there is an acute metabolic or toxic event due to factors (such as alcohol, drugs, eclampsia, nonketotic hyperglycemia) 
○ Other _______________________________________ 
○ 5) Lack of information 
 
Signature :  
 
○ 
2) Generalized epilepsy: the presence of one or more of the findings below and no findings to suggest 
localization-related epilepsy (tuberous sclerosis or other focal cortical abnormalities does not rule out 
generalized epilepsy)  
○ 
2) Generalized epilepsy: the presence of one or more of the findings below and no findings to suggest 
localization-related epilepsy (tuberous sclerosis or other focal cortical abnormalities does not rule out 
generalized epilepsy)  
